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Abstract: Domain swapping is a term used to describe a process when two or more protein chains exchange identical 
structural elements. Some cases of amyloid formation can be explained through a domain swapping mechanism therefore 
this deserves theoretical consideration and studying. It has been demonstrated that diverse proteins in sequence and 
structure are able to oligomerize via domain swapping. This allows us to suggest that the exchangeable regions are 
important in folding and misfolding processes of proteins, i.e. the residues from the swapping regions are typically 
incorporated into the native structure early during its formation. The modeling of folding of the proteins with swapped 
domains demonstrates that the regions exchanged in the oligomeric form in most cases are also responsible for folding 
and misfolding. For 11 out of 17 proteins, swapping regions intersect with the predicted amyloidogenic regions. 
Moreover, for 10 out of 17 proteins, high -values (>0.5) belong to residues from the swapping regions. Our data confirm 
that the exchangeable regions are important in folding, misfolding, and domain swapping processes of the proteins, 
therefore the suggestion that domain swapping can serve as a mechanism for functional interconversion between 
monomers and oligomers is likely to be correct.  
Keywords: Folding, misfolding, swapping mechanism, amyloid formation, oligomerization, folding nucleus. 
INTRODUCTION 
  Eisenberg and his colleagues [1, 2] have proposed a 
mechanism for protein oligomerization, 3D domain 
swapping. In a domain swapping oligomer, one segment of a 
monomeric protein is replaced by the same segment from 
another chain. Some cases of amyloid formation can be 
explained through a domain swapping mechanism where the 
swapped segment is either a beta-hairpin or another 
conformation.  From the time of definition of domain 
swapping in diphtheria toxin [1], three-dimensional domain 
swapping has been observed in more than 40 different 
proteins, among them in such amyloidogenic proteins as 
prions [3, 4], beta2-microglobulin [5, 6], cystatins [7-11], 
and in such important proteins as p13suc1 [12-15], interferon 
[16, 17] and others.  The  understanding of oligomerization 
via  domain swapping is important for theoretical and 
practical tasks because a swapping mechanism is critical for 
some protein functions [12-15]. 
  For p13suc1 it has been demonstrated that domain 
swapping and aggregation correlate, which suggests that they 
share a common mechanism [14]. It has been established that 
p13suc1 from fission yeast belongs to the Cks protein family 
[18] and is required for the function of cyclin-dependent 
kinase (Cdk) proteins during cell cycle progression [19]. 
p13suc1 has two native states, a monomer and a domain-
swapped dimmer, and the monomer-dimer equilibrium is 
controlled by two conserved prolines in the hinge loop. The 
X-ray crystal structure of p13suc1 at 1.95 Å resolution was  
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reported [12] (see Fig.1g and Table 2, row 17). The domain-
swapped part of suc1 is a single -strand that cannot 
constitute an independently folded subdomain [12, 13]. To 
confirm this, the protein engineering analysis of the folding 
pathway of the monomer has been performed [13]. The 
experimental data on the transition state structure is 
expressed in f values [20]. f is close to 1 when a residue 
has its native conformation and environment in the transition 
state and to 0 when the residue is unfolded in this state. The 
exchanging strand in suc1, 4, forms critical contacts with 
the rest of the protein in the folding nucleus and the -values 
for the hinge residues are between 0.5 and 0.8 [13]. Thus, 
folding and association should be tightly coupled, with 
pairing of 2 and 4 occurring early in the folding pathway 
of the dimer. So, it has been demonstrated for one protein 
that the exchangeable region is responsible for folding and 
misfolding. 
  Since polypeptide chains can fold into native structures 
or misfold into amyloid fibrils, there is a competition 
between the processes of folding and misfolding. A crucial 
event of protein folding is the formation of a folding nucleus, 
which is a structured part of the protein chain in the 
transition state. It has been demonstrated that there is a 
correlation between locations of residues involved in the 
folding nuclei and locations of predicted amyloidogenic 
regions [21, 22]. It has been demonstrated also that the 
average  -values are significantly greater inside 
amyloidogenic regions than outside them [21-23]. We have 
found that fibril formation and normal folding involve many 
of the same key residues, giving an opportunity to outline the 
folding initiation site in protein chains [21]. 28    The Open Biochemistry Journal, 2011, Volume 5  Oxana V. Galzitskaya 
  The goal of this work is to compare amino acid residues 
which are crucial for folding, misfolding, and swapping 
processes of the same proteins.  
  One can hypothesize that regions which are responsible 
for aggregation and protein folding will often appear as 
swapping regions in the proteins with swapped domains. For 
this purpose we collected 17 pairs with known 3D structures 
of swapped domains in the oligomeric form and 3D 
structures of the monomeric form. For these proteins, we 
calculated the amyloidogenic/aggregation regions using our 
program (FoldAmyloid/FoldUnfold) [24, 25] and for the 
monomeric form of proteins we calculated -values for each 
residue also using our approach [26]. 
  The modeling of folding of the protein with swapped 
domains demonstrates that in most cases the regions 
exchangeable in the oligomeric form are also responsible for 
folding and misfolding. After considering examples of 3D 
domain swapping it has been suggested that domain 
swapping can serve as one of the mechanisms for functional 
interconversion between monomers and oligomers and as 
one of the mechanisms for evolution of some oligomeric 
proteins [2]. 
MATHERIALS AND METHODOLOGY 
Prediction of Amyloidogenic Regions in Proteins 
  For prediction of amyloidogenic regions, we used the 
previously described [24, 25, 27, 28] method of prediction of 
regions with a large number of contacts per residue in 
protein sequences. For each amino acid residue in the protein 
sequence, an expected number of contacts per residue are 
attributed according to the type of the residue (which is the 
average number of contacts at a distance below 8 Å for the 
given type of residues in 3D structures of proteins [27, 28]). 
Then, the values are averaged with a sliding window of 
seven (or five) residues [25]. In the obtained profile, the 
regions within which all residues have values above the 
threshold (21.4 expected contacts per residue) are predicted 
as amyloidogenic if the size of such a region is not smaller 
Table 1.  Comparison of Predictions of Amyloidogenic Regions by Different Methods 
Regions predicted  Name of 
the protein 
PDB 
entry 
Experimentally investigated 
amyloidogenic regions  by our method  by Tango  by Zyggregator 
Acylphosphatase 1aps   
16-31 [29]; 
87-98 [29] 
 
19 – 25
a; 
91 - 98 
- 
 
19 - 20; 
36 - 37 
2-microglobulin 1im9  20-41  [30]; 
59-71 [31]; 
83-89 [6] 
24 - 30; 
60 - 70 
61 - 69  24 - 26; 
63 - 66 
Gelsolin  1kcq  52-62 [32]  1 - 7  -  30; 
32 -33; 
40 - 41 
Transthyretin  1bm7  10-19 [33];  
105-115 [34] 
10 - 17; 
28 - 34; 
105 - 113 
107 - 111  28; 
93 - 94; 
117 - 118 
Lysozyme  193l  49-64 [35]   25 - 31; 
54 - 65; 
106 - 113; 
121 - 129 
-  25 - 26; 
28 - 29; 
31; 
55 - 56 
Myoglobin 1wla  7-18  [36]; 
101-118 [37]  
8 - 14; 
27 - 33; 
100 - 116; 
134 - 140 
66 - 72  10 - 12; 
14; 
67 - 70; 
104; 
109 
Human prion  1qm0  169-213 [38]   136 - 142; 
159 - 166; 
176 - 183 
-  126 - 128; 
177 - 179; 
190; 
212 - 213; 
215 
aBold type is used for the predicted regions which intersect with the experimentally obtained data. Regions which are Responsible for Swapping  The Open Biochemistry Journal, 2011, Volume 5    29 
than the sliding window [25, 27, 28]. Thus, the predicted 
amyloidogenic regions are those which have a large number 
of expected contacts per residue. 
  We tried to predict amyloidogenic regions not only by 
our method but by other methods allowing (as stated by their 
authors) to predict amyloidogenic regions. But at first, we 
decided to test the quality of the predictions of these methods 
(as well as of our method) on the seven proteins for which 
amyloidogenic fragments are experimentally known. We 
used TANGO (dis.embl.de) and ZYGGREGATOR 
(http://www-vendruscolo.ch.cam.ac.uk/zyggregator.php). 
The predictions we made using all the three methods are 
shown in Table 1. 
  One can see that TANGO does not find the largest part of 
experimentally revealed amyloidogenic fragments (only two 
of 12 experimental amyloidogenic regions are correctly 
predicted, and one (for myoglobin) is in the wrong place). 
ZYGGREGATOR works better for this set of proteins 
(seven of 12 amyloidogenic regions are correctly predicted, 
that is, intersect with real amyloidogenic fragments) but 
ZYGGREGATOR predictions are still worse compared to 
our method (we predict correctly 10 of 12 experimentally 
revealed amyloidogenic fragments). 
  As both methods do not give good predictions of 
amyloidogenic regions for proteins for which the quality of 
predictions can be evaluated, we could not add predictions 
made by these methods to our manuscript. 
Theoretical Search for Folding Nuclei 
  We model the process of reversible unfolding of the 
protein "normal" (native) globular structure into the unfolded 
state at the point of thermodynamic equilibrium (where the 
free energies of the folded and unfolded states are equal). 
Under these conditions, only the completely folded and 
completely unfolded states are observed while all other states 
(misfolded, partially folded etc.) are destabilized. The 
pathways of folding and unfolding coincide and all dead-
ends are destabilized, so the protein chain behavior can be 
approximated as a reversible folding/unfolding process. 
  We start from a known tertiary structure of the 
investigated protein in the native state and stepwise unfold 
its amino acid residues. A link of five residues is unfolded in 
a single step (this link size was shown to be optimal for 
predictions of folding nuclei in globular proteins) [39]. 
Finally, we obtain a completely unfolded state. The unfolded 
residues lose all contacts that existing in the tertiary structure 
but gain the entropy of the coil (except for the entropy which 
is expended on fixation of unfolded loops that protrude from 
the folded part of the structure). Thus, any amino acid 
residue in our model can exist in one of the two states: 
folded, where it has all of its native contacts with the other 
folded residues, and unfolded, where it has no contacts but 
has higher entropy. 
  Considering all the ways of  protein structure unfolding, 
we obtain a network of protein folding/unfolding pathways. 
The free energy of any state is calculated as follows: 
F(I) =   nI T[I  + Sloop
loops  I  ],         (1) 
where  nI  is the number of native atom-atom contacts in the 
native-like part of I (nI  does not include contacts of 
neighbor residues, which also exist in the coil; in this work, 
we consider two atoms to form a contact if their centers are 
separated by less than 6Å, which is the optimal value of this 
parameter for folding nuclei predictions [39]);  is the energy 
of one contact (all contacts are assumed to be equal in 
energy); I is the number of residues in the unfolded part of 
I; T is the temperature;  is the entropy difference between 
the coil and the native state of a residue (we take  =2.3R 
[40], where R is the gas constant). The sum  is taken for all 
closed unfolded loops that protrude from the native-like part 
of I. For the loop between fixed residues k and l,  Sloop  is 
calculated as follows [41]: 
Sloop = 
5/2R ln|k  l|  
3/2R (r
2
kl  a
2) / (2Aa|k  l|),         (2) 
where rkl is the distance between the C atoms of residues k 
and  l,  a  = 3.8Å is the distance between the neighbor C 
atoms in the chain, and A is the persistence length for a 
polypeptide (according to Flory [41], we take A = 20Å). The 
term 
5/2 R ln|k  l| is the most significant in this equation; 
the coefficient 
5/2 (rather than Flory's value 
3/2) follows 
from the condition that the loop cannot penetrate inside the 
globule [42]. 
Calculation of -Values 
  Since in our model all native contacts have equal energy 
and non-native contacts are absent, the -value is a fraction 
of native contacts formed in the transition state compared to 
the native state [39]: 
 = <r(nI)>I# / r(n0),               (3) 
where  r(n0) is the number of contacts deleted by the 
mutation in the given amino acid residue r in the native state 
of the protein while <r(nI)>I# is the number of contacts 
deleted by the mutation averaged over all transition states 
found with our method. We consider all mutations on Gly; if 
a residue in the wild-type protein is already Gly, we take its 
probability to be structured in the transition state ensemble 
[26]. 
Creation of a Database of Swapped Proteins 
  First, all entries where a word "swap" was met were 
selected from the PDB database. Then all these entries were 
manually processed and those where the word "swap" was 
not related to real swapping were excluded according to the 
SCOP [43]. Multi-domain proteins and proteins with split 
domains (consisting with non-continuous chains) according 
to the SCOP were excluded. Large proteins (larger than 200 
amino acid residues) were also excluded. For each protein, a 
non-swapped 100% homolog has been found using BLAST 
[44]. If a swapped protein had no non-swapped 100% 
homolog, the protein was excluded. There are 16 pairs where 
we have PDB entries for swapped and non-swapped 
structures (see Table 2). Visual inspection of the spatial 
structures has been done to explain which region of non-
swapped structure was swapped in the swapped structure. 
One additional pair for suc1 protein has been added because 
the X-ray structure for the monomeric form was provided by 30    The Open Biochemistry Journal, 2011, Volume 5  Oxana V. Galzitskaya 
J. Schymkowitz in 2001 and later this protein was studied by 
us [36]. 
RESULTS AND DISCUSSION 
Modeling of Folding of Proteins with Swapped Domains. 
Intersection of Experimentally Determined Swapping 
Regions with the Predicted Folding Nuclei 
  One can hypothesize that regions which are responsible 
for aggregation and protein folding will often appear as 
swapping regions in the proteins with swapped domains. For 
this purpose we collected 17 pairs with known 3D structures 
of swapped domains in the oligomeric form and 3D 
structures of the monomeric form. 
  Using a theoretical method, we searched for the position 
of the folding nuclei in the 3D structures of the monomeric 
form during their "normal" folding process from the 
unfolded state into their folded native structure. Using the 
method which (as we have previously shown earlier [26, 39, 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (1). Predicted -value profiles for weight investigated proteins. For each protein, the average -value inside swapping and over non-
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45]) allows predicting the position of folding nuclei 
reasonably well (the correlation coefficient between 
predicted and experimentally known -values reaches 65% 
if the native 3D structure used in the modeling is of high 
quality, see [39]), we modeled the behavior of each protein 
molecule at the point of thermodynamic equilibrium (i.e. 
under the conditions when unfolded and native states are 
equally stable and all the other states are unstable). The 
behavior of the protein molecule is modeled as a simplified 
sequential reversible unfolding of its known native 3D 
structure (see MATERIALS AND METHODOLOGY). The 
obtained network of folding/unfolding pathways is further 
analyzed by the dynamic programming method [46] to find 
transition states and (correspondingly) folding nuclei. The 
involvement of a residue in the folding nucleus (or rather, in 
the ensemble of the folding nuclei) is reflected in its -
value, which is unity when this residue has all of its native 
contacts in the transition state and zero when this residue has 
no contacts in the transition state.  
  We tested whether the theoretically found folding nuclei 
(-values larger than 0.5) intersect with the experimentally 
found swapping regions. It appears that for 10 out of 17 
proteins, high -values (> 0.5) belong to residues from the 
swapping regions (such pdb files are given in the bold type, 
the last column in Table 2 ). The profiles of -values for 
eight proteins are shown in Fig. (1). For cystatin A, the 
average predicted -value inside swapping regions is higher 
(0.63) (see Fig. (1a)) than in the non-swapping one (0.33). 
The average predicted -value for prion molecule inside 
swapping regions is higher (0.75) than in the non-swapping 
one (0.53). In Fig. (1b) one can see that the C-terminus of 
the prion molecule has higher -values than the N-terminus. 
Moreover, the average predicted -value inside 
amyloidogenic regions is higher (0.79) than in the non-
amyloidogenic one (0.43) [23]. At the same time the average 
predicted  -value for a barnase molecule inside swapping 
regions (1-37) is lower (0.35) than in the non-swapping one 
(0.49), and in addition it is less than 0.5. 
  Thus, we demonstrate that theoretically found folding 
nuclei (-values larger than 0.5) intersect with 
experimentally found swapping regions. This means that 
swapping regions are likely to be present in the folding 
nucleus of a protein when the protein folds into its native 
structure. 
Intersection of Predicted Amyloidogenic Regions with 
Experimentally Determined Swapping Regions 
  Previously we have demonstrated that amyloidogenic 
regions are often predicted to be part of the folding nuclei in 
amyloidogenic proteins [21-23]. Therefore, we can 
hypothesize that amyloidogenic regions often play a crucial 
role not only in the amyloid fibril formation but also in the 
process of "normal" folding of amyloidogenic proteins into 
their native structure, since amyloidogenic regions compose 
part of the folding nucleus in these proteins. Inasmuch as 
some cases of amyloid formation can be explained through a 
domain swapping mechanism one can suggest that regions 
responsible for the amyloid formation will intersect with 
swapping regions. 
  Further, we have compared the predicted amyloidogenic 
regions for the 17 proteins where swapping regions have 
already been outlined experimentally. The prediction of 
amyloidogenic regions was made by the previously 
described [25, 27, 28] method (see also MATERIALS AND 
METHODOLOGY) which predicts amyloidogenic regions 
using only the amino acid sequence. For each amino acid 
residue, the method predicts the number of expected contacts 
and the regions within which all residues with a large 
number of expected contacts are predicted as amyloidogenic 
regions. As demonstrated previously [25], this method is 
able to predict amyloidogenic regions. 
 In  Table  2, the predicted amyloidogenic regions for each 
of the 17 investigated proteins are shown. One can see that 
for 11 out of 17 proteins, swapping regions intersect with the 
predicted amyloidogenic regions (such pdb files are given in 
bold, third column). It should be noted that practically in all 
cases the swapping region is at the termini of the protein 
chain. 
  Thus, both comparisons (predicted folding nuclei vs. 
experimentally known swapping fragments and predicted 
amyloidogenic fragments vs. experimentally known folding 
nuclei) indicate that the location of swapping regions 
intersects with both the folding nuclei and the location of 
amyloidogenic regions. In other words, nucleation centers 
for folding and for misfolding and swapping regions often 
intersect.  
Description of Globular Proteins Involved in 
Amyloidogenesis 
  Several important cases deserve a special consideration. 
It has been shown that such proteins as the cystatins and the 
prions can form dimers via  a three-dimensional domain 
swapping mechanism which may be involved in 
amyloidogenesis as has been hypothesized [3, 4, 7-11].  
  Cystatins were the first amyloidogenic proteins which 
oligomerize through a 3D domain swapping mechanism [7]. 
It has been shown that oligomerization of human cystatin C 
leading to amyloid deposits in blood vessels is greatly 
accelerated with a naturally occurring Leu68Gln variant 
resulting in fatal amyloidosis in early adult life (Patients 
suffer such disease as Hereditary Cystatin C Amyloid 
Angiopathy which is a rare fatal amyloid disease) [10, 47]. It 
has been demonstrated that higher aggregates for cystatin C 
may arise through a domain-swapping mechanism when 
partially unfolded molecules are linked into multitude chains 
[9]. For cystatin A the N-terminal part of the molecule 
consisting of two beta-strands and one helix is exchanging 
under formation of domain swapping. It has been shown that 
the large conformational perturbation is needed for domain 
swapping  [8]. It should be underlined here that the N-
terminal part of the cystatin A has high predicted -values. 
This confirms the hypothesis that regions which are 
important for folding are also important for swapping. 
  The crystal structure of human prion protein in a dimer 
form at 2 Å resolution has been described [3]. The dimer 
results from the three-dimensional swapping of C-terminal 
helix 3 and the rearrangement of the disulfide bond. An 
interchain two-stranded antiparallel beta-sheet is formed at 
the dimer interface by residues that are located in helix 2 in 
the monomeric NMR structures [3].  32    The Open Biochemistry Journal, 2011, Volume 5  Oxana V. Galzitskaya 
Table 2.  Prediction of Amyloidogenic Regions for Proteins with Swapping Domain 
 
SCOP class, name, 
and number of 
residues 
PDB file with swapped structure 
Predicted 
amyloidogenic 
regions 
Location 
of 
swapped 
region 
PDB file with non-swapped structure 
1 
a, PECTIN 
METHYLESTERA
SE INHIBITOR, 
153 
 
1x8z
a 
20-27 
70-74 
140-148 
1-31 
 
1x91 
2 
a, CALBINDIN 
D9K, 76 
 
1ht9 
30-35 
68-72 
45-76 
 
1ksm
b 
3 
b, T-CELL 
SURFACE 
ANTIGEN CD2, 94 
1a6p 
16-20 
72-26 
89-94 
1-41 
 
1hng 
4 
b, NERVE 
GROWTH 
FACTOR 
RECEPTOR 
TRKA, 109 
 
1wwa 
14-22, 32-36 
45-51, 62-67 
93-98 
1-19 
 
1www 
5 
b, CYANOVIRIN-
N, 101 
 
1l5b 
53-57 1-51 
 
2ezm 
(CASP3) 
6 
c, SPORULATION 
RESPONSE 
REGULATOR 
SPO0A, 130 
 
1dz3 
1-7, 
51-59 
65-69, 80-85 
101-106 
114-120 
108-130 
 
1qmp 
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SCOP class, name, 
and number of 
residues 
PDB file with swapped structure 
Predicted 
amyloidogenic 
regions 
Location 
of 
swapped 
region 
PDB file with non-swapped structure 
7  d, BARNASE, 110 
 
1yvs 
1-6, 
12-16 
33-37, 92-98 
1-37 
 
1a2p 
8 
d, 
IMMUNOGLOBU
LIN G BINDING 
PROTEIN G, 56 
 
1q10 
1-7 
31-35 
38-56 
 
1pgb 
9 
d, CYSTATIN A 
(stefin A), HOMO 
SAPIENS, 98 
 
1n9j 
52-57 
64-69 
80-84 
1-48 
 
1gd4 
10 
d, PROTEGRIN-3 
PRECURSOR, 101 
1lxe 
3-12 
24-30 
1-38 
 
1n5h 
11 
d, PROTEIN-
TYROSINE 
PHOSPHATASE 
YOPH, 136 
 
1k46 
40-44 
64-68 
115-119 
1-29 
 
1m0v 
12 
d, 
RIBONUCLEASE 
A, 124 
1f0v 
105-109 
116-120 
114-124 
 
1kf3 
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SCOP class, name, 
and number of 
residues 
PDB file with swapped structure 
Predicted 
amyloidogenic 
regions 
Location 
of 
swapped 
region 
PDB file with non-swapped structure 
13 
d, 
RIBONUCLEASE 
A, 124 
 
1a2w 
105-109 
116-120 
1-20 
 
 
1kf3 
14 
d, MAJOR PRION 
PROTEIN (human), 
fragment 119-226, 
108 
 
1i4m 
18-23, 29-34 
56-60, 62-66 
93-99 
75-108 
 
1qm2 
15 
d, SH2 DOMAIN, 
114 
 
1fyr 
12-16 
59-63 
70-77 
98-102 
76-114 
 
1bmb 
16 
d, CATABOLITE 
REPRESSION 
HPR, 87 
 
1mo1 
20-24 
48-53 
1-12 
 
1k1c 
17 
d, 
P13SUC1, 
105 
 
1puc 
22-26 
36-42 
81-86 
92-97 
94-102 
(89-102 
for 1suc) 
 
1suc
c 
apdb files are given in bold if one of the predicted amyloidogenic regions intersect with the swapping regions. Such regions are also given in bold in the fourth column and highlighted 
by yellow color in the monomer structures (last colomn).  
bpdb files are given in bold if the average predicted -values belonging to the swapping regions are larger than 0.5. 
cX-ray structure for the monomeric form has been provided by J. Schymkowitz in 2001 year. In this structure 5 N-terminal and 11 C-terminal residues have no coordinates.  
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  In the partially unstructured human prion protein, we 
predict an amyloidogenic region detected by experimentally 
(169-213 [38]). The first -helix near the N-terminus 
appeared to have lower protection to solvent exchange 
compared to the other helices [48]. The N-terminus of the 
molecule appears to be predisposed to adopt multiple 
conformations that may feature in the transition from PrP
C to 
the toxic PrP
Sc form [48]. It has been shown that this fast-
folding protein has a transition state that is not compact (the 
m value analysis gives a t value of only 0.3) but contains a 
developing nucleus between helices 2 and 3 [49]. This is in 
agreement with our prediction (see Fig. 1b) where residues 
corresponding to the second and third helices have high -
values. There are two residues with large -values (V180 
and M206), both of which are squarely on the interface 
between helix 2 and helix 3. These residues form the major 
part of the contact area in the central region of this 
interaction. The authors of the paper underline that if a 
mutation in the nucleus had a negligible effect on stability 
but still led to the formation of irregular conformations 
during folding then one should suggest an easily perturbed 
folding mechanism for such a protein [49]. It is notable that 
in inherited forms of human prion disease, where point 
mutations produce a lethal dominant condition, 20 of the 33 
amino acid replacements occur in helices 2 and 3 (i.e. 
mutations map to the regions directly involved in helix 
swapping [49]). This crystal structure suggests that 
oligomerization through 3D domain-swapping may 
constitute an important step on the pathway of the PrP(C) --> 
PrP(Sc) conversion [3]. 
  It should be mentioned here that the two proteins 
considered in this section are involved in the disease. For 
these proteins we observe intersection between regions 
important for folding and misfolding. This confirms our 
hypothesis that if the regions which are important for folding 
intersect with the regions which are responsible for amyloid 
formation, then such proteins can with higher probability 
misfold in appropriate environmental conditions to amyloid 
fibrils involved in vivo in various “amyloid” diseases. 
  By modeling the folding of 17 proteins with swapped 
domains we observe that regions, that are responsible for 
swapping, are also responsible for folding and misfolding. 
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